http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0603383-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b339667a9c5df0c16e3d15f595f382c8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 1993-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7cdd35f31106772882c1034e9e757ced |
| publicationDate | 1994-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-0603383-A1 |
| titleOfInvention | Compositions and methods for treating autoimmune diseases |
| abstract | The present invention relates to methods for treating autoimmune diseases in humans by administering, to a host suffering therefrom, pharmaceutical compositions containing a therapeutically effective amount of a combination of (A) and (B) in a weight ratio ranging from about 1: 1 to about 1:10 (A: B); where R is OH, NH2, OW, or H; X is H, F, C1, Br, I, OH, OW, NO2, or NH2; Y is H, F, C1, Br, or I; W is (1) or a C1-C12 aliphatic group; Z is an aliphatic or aromatic group C1-C12; X and Y can both vary within the compound; or their pharmaceutically acceptable salts. Is particularly described a composition containing a proportion of 1 to 4 sodium salts of phenyleacetyleglutamine and phenylacetic acid, formulated in both oral and parenteral forms clinically useful in the treatment of rheumatoid arthritis, lupus erythematosus, vasculitis , insulin-dependent diabetes mellitus and multiple sclerosis. |
| priorityDate | 1992-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.